Makers of consumer products need faster, better methods for predicting relative safety of new ingredients and alternative formulations of existing products. In light of increased pressure from regulatory bodies and consumers to reduce or eliminate animal testing, in vitro and in silico alternatives are needed to continue development of new product lines while ensuring safe consumer use.
ScitoVation specializes in identifying the effects of chemical combinations on human cells. By combining quantitative data generation functions with systems-based data analytics, exposure estimates and computational modeling, we provide a unique integrated approach to addressing potential hazards to human health.
From mode-of-action characterization to identification of potential adverse outcomes, our multidisciplinary teams provide maximum value and efficiency in assessing risk from consumer, industrial and agricultural chemicals so companies can prioritize development efforts toward making safer products.